{"id":"W4399926328","doi":"10.1016/j.esmoop.2024.103537","title":"37MO Dostarlimab plus chemotherapy in primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: Overall survival (OS) by MMR status and molecular subgroups","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Endometrial cancer; Oncology; Medicine; Internal medicine; Overall survival; Chemotherapy; Gynecology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009140515,0.0003311627,0.0008434257,0.0002865899,0.00004917439,0.0002030812,0.0003462396,0.0001356231,0.0007688212],"category_scores_gemma":[0.0002432421,0.0002028966,0.0001167476,0.001400683,0.00006549145,0.0002677435,0.0001569157,0.0004840054,0.00001135925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009294714,"about_ca_system_score_gemma":0.0005734588,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009428015,"about_ca_topic_score_gemma":0.001819333,"domain_scores_codex":[0.9973252,0.0003018215,0.0005636115,0.0006587212,0.0005897156,0.0005609719],"domain_scores_gemma":[0.9986345,0.0007142876,0.0000899109,0.000347356,0.00003528781,0.0001786496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5141476,0.002083768,0.008121471,0.0005393233,0.0007042235,0.001118374,0.002661975,0.00001637758,0.001445805,0.0007436122,0.004757523,0.4636599],"study_design_scores_gemma":[0.6159534,0.00681103,0.0358829,0.001037937,0.0003157112,0.00002448665,0.0004861218,0.0000751619,0.00274374,0.0008966117,0.3349317,0.0008412168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9687595,0.0150076,0.00001287698,0.004393514,0.001490973,0.005392506,0.000195593,0.00004534072,0.004702132],"genre_scores_gemma":[0.979187,0.0146014,0.0002648879,0.003009653,0.0003892547,0.00126459,0.0003161897,0.00008144506,0.0008855864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4628187,"threshold_uncertainty_score":0.9971683,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03420991255425919,"score_gpt":0.3512152869362682,"score_spread":0.317005374382009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}